Upload
universidad-de-sevilla
View
216
Download
0
Embed Size (px)
Citation preview
8/18/2019 Bipolar Disorder Assessment and Management
1/57
B@ >B@ >=>=>=>=>
C<
&../>/185
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016
http://nice.org.uk/guidance/cg185http://nice.org.uk/guidance/cg185
8/18/2019 Bipolar Disorder Assessment and Management
2/57
C>>C>>
I>> .......................................................................................................................................................................... 4
> .................................................................................................................................................................... 5
D ==>>................................................................................................................................................................. 5
&>-> .......................................................................................................................................................... 6
! @ =@>................................................................................................................................ 7
C > @@ =>> @ @= ....................................................................... 7
#>> => @=> > > ........................................................................................... 7
#>> @ > > ............................................................................................... 8
#>> @ = > > .............................................................. 9
>>, >> > =>> @ > > @@> ..........................................................................................................................................................12
*= > ......................................................................................................................................................... 12
1.1 C > @@ =>> @ @= ................................................................ 16
1.3 A> @ @ > ....................................................................... 19
1.4 #>> , > 20
1.5 #>> => @=> > > .................................................................................... 21
1.6 #>> @ > > ....................................................................................... 23
1.7 #>> @ = > > ....................................................... 25
1.8 #>> @< > .............................................................................................................. 28
1.9 &=> > > @= .......................................................................................................... 29
1.10 H => ........................................................................................................................................................ 30
1.11 >>, >> > =>> @ > > @@> .......................................................................................................................................43
2.1 &>> > @@>> =>......................................................................................................................................................... 43
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 2 ' 57
8/18/2019 Bipolar Disorder Assessment and Management
3/57
2.3 A>@> => >=> => > @ ................................................ 44
2.4 A @ < C > $ICE @ =..........50
4.1 G D G@ ........................................................................................................................................... 50
4.2 $>< C #>< H @................................................................................................................................................53
A ...........................................................................................................................................................54
+@ >=>......................................................................................................................................................................... 54
> ==>>.................................................................................................................................................... 54
> ................................................................................................................................................. 55
I=@> ................................................................................................................................................................................ 56
@>
8/18/2019 Bipolar Disorder Assessment and Management
4/57
* @>I>>
* > @ > @= @
@ =. I > = > , >
=, @> >> N @ (ADHD).
* @ > 15L19 , > > >< > > N
> =>< ) = 1% @ >
@>) @@= @ @ ($ICE < 38) > 2006, >
= =@> > > > => @@
= > =>=> @ ,
> @@ > > > > >
@@> > @ > =@>
ADHD. * ==>> @@ = @N ==>> =><
==>
8/18/2019 Bipolar Disorder Assessment and Management
5/57
S"'&("%*/( $)*%&/
==
> @> >, => @=>, @= > > >
==> > ( = > = >< @>.
* ==> = >> > +! =>
> @, > @@ . *
@ .
* @> ( >> > >, . G>< #< C>
8/18/2019 Bipolar Disorder Assessment and Management
6/57
&&>-> >->
* @ > > @@ E> L > O .
*=> > > >< > > @>. &@= > > =>, > @>@
> 16, = > @@ =>. H>: > > @@ @@ =>=> > @, > >
.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 6 ' 57
https://www.gov.uk/government/publications/the-nhs-constitution-for-englandhttps://www.gov.uk/government/publications/reference-guide-to-consent-for-examination-or-treatment-second-editionhttp://www.justice.gov.uk/protecting-the-vulnerable/mental-capacity-acthttp://www.justice.gov.uk/protecting-the-vulnerable/mental-capacity-acthttp://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_085476http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_085476http://www.nice.org.uk/guidance/cg138http://www.nice.org.uk/guidance/cg138http://www.nice.org.uk/guidance/cg136http://www.nice.org.uk/guidance/cg136http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4132145http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4132145http://www.nice.org.uk/guidance/cg136http://www.nice.org.uk/guidance/cg136http://www.nice.org.uk/guidance/cg138http://www.nice.org.uk/guidance/cg138http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_085476http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_085476http://www.justice.gov.uk/protecting-the-vulnerable/mental-capacity-acthttp://www.justice.gov.uk/protecting-the-vulnerable/mental-capacity-acthttps://www.gov.uk/government/publications/reference-guide-to-consent-for-examination-or-treatment-second-editionhttps://www.gov.uk/government/publications/the-nhs-constitution-for-england
8/18/2019 Bipolar Disorder Assessment and Management
7/57
!! @ =@> @ =@>
* > > >N @ =@>. * > > 1.
C"& ' "%, $)*%&/ "/% /( && "$ " )"& ' #*" %*%&
@@ @@ >N> > >=> > >
>> @>' @@. F >
>@>>2
.
R&$(/**/( "/% "/"(*/( #*" %*%& */ "% */ *" $"&
#>> @ @= #>> @ @=
@@> > > (> < @,
>@>< @ < @ ==>>
1.5.3.1L1.5.3.5 > $ICE < > @>.
D @> @N > @>>
> @>. #> = > > @=> >
@ =@=, > . I
@> @>, = > .
M"/"(*/( "/*" )"/*" */ "% */ &$/%" $"&
&=&=>>>>
I @> @=> > > > > >@ = , > > > > >
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 7 ' 57
http://www.nice.org.uk/guidance/cg185/chapter/recommendationshttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations
8/18/2019 Bipolar Disorder Assessment and Management
8/57
=>, @>' @> > < > (> @< =,
@ @> => > ). F > >
>@ > > 1.10.
I @> , @>>
> @>' @> > @ @> =>.
M"/"(*/( #*" %&&*/ */ "% */ &$/%" $"&
&&>>>>
> > > (> < @,
>@>< @ < @ ==>>
1.5.3.1L1.5.3.5 > $ICE < > @>.
D @> @N > @>>
> @>. #> = > => @=> >
@ =@=.
&=&=>>>>
I @> > >
@3
=> J@>4
, @> > >,
@>> > @>' @> > @ @> =>.
I @> @, > J@> ( O>) 5 >
>.
I > @> O> => J@>, @>, >
> >.
F > > >@ > > > 1.10.
I @>
8/18/2019 Bipolar Disorder Assessment and Management
9/57
8/18/2019 Bipolar Disorder Assessment and Management
10/57
R&$(/**/(, %*"(/*/( "/% "/"(*/( #*" %*%& */ $)*%&/ "/% /(
&&
>> > >> > @ > @@, @@ >< =>> < = > @> > =>, > > =>=> @ > > @@ > '
@> .
#>=> > #>=> > > @@ @@ @=> > > @@ > @- =>< >
> +! < @, = @ (@= 2014),
O> > +! => > >>. * @ . I>= >>
> =>. G>< #< C>
8/18/2019 Bipolar Disorder Assessment and Management
11/57
8/18/2019 Bipolar Disorder Assessment and Management
12/57
11 ==>>==>>
* > > , > @@
@ @@ ==>> > ( =@ '>') > > ==>> = ( >
==>>). @ >@ @@ @>, = >
* @ N> > $ICE < >
@> 5 = >,
=@= > => >>< =@=>.
M%&"& %&&*/ =@= >>< =@=> > = .
S&&& %&&*/ # =@=, =@= => >>>. C>
@ =@=.
E>- =>- =>< A =>< > = > > >>> > > @> =@=
> @ , > -= =>, > @@
8/18/2019 Bipolar Disorder Assessment and Management
13/57
>> =>
> @@ @> => =-= =
@> => @>
8/18/2019 Bipolar Disorder Assessment and Management
14/57
1.1.5 E> @@ > => > @@ @@ N @ , > >
=, => > $ICE < , > >
=> @
>< @>> N
@ , > > @ > > =, < >> >
< =>.
1.1.8 @@>
@@
> @@ @@I>=> > @@
1.1.9 C> >> > > > >, N>>< >
=@ @. I @> @ @@.
1.1.10 E> @@ @ > >< @
@=>.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 14 ' 57
http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg77http://www.nice.org.uk/guidance/cg78http://www.nice.org.uk/guidance/cg72http://www.nice.org.uk/guidance/cg72http://www.nice.org.uk/guidance/cg113http://www.nice.org.uk/guidance/cg120http://www.nice.org.uk/guidance/cg120http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg120http://www.nice.org.uk/guidance/cg120http://www.nice.org.uk/guidance/cg113http://www.nice.org.uk/guidance/cg72http://www.nice.org.uk/guidance/cg72http://www.nice.org.uk/guidance/cg78http://www.nice.org.uk/guidance/cg77http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guideline
8/18/2019 Bipolar Disorder Assessment and Management
15/57
@@ @@ >
. D >N >, @ > G& > > >> >@>>10
.
1.1.16 , @ > >
11
.
1.1.17 I> >-=> @> 10
.
1.1.18 - > > @@ @==, = @
=>> @
8/18/2019 Bipolar Disorder Assessment and Management
16/57
, > @@ > >, > @> @:
> > => > @
.
1.2 R&$(/**/( "/% "/"(*/( #*" %*%& */ "% */ *" $"&
>> @ @= > >> @ @= > > @= @>, @
@ > . I
> <
@< .
1.2.2 @@
@> @ > = >> > @= > @ > @ @= #>> @ @=
1.2.4 > > @@ > >> @ = >
@@ = @ > >
> , > =>, > @>, < > >>.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 16 ' 57
http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guideline
8/18/2019 Bipolar Disorder Assessment and Management
17/57
1.2.5 @@> > > (> < @,
>@>< @ < @ ==>>
1.5.3.1L1.5.3.5 > $ICE < > @>.
D @> @N > @>>
> @>. #> = > > @=>
> @ =@=, >
. I @> @>, = > .
1.2.6 & @@ @=
> > > @> > @@=>.
1.2.8 D > @= @ >
@>' >>> >N> > @
@> @@> > => @ > @>>.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 17 ' 57
http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guideline
8/18/2019 Bipolar Disorder Assessment and Management
18/57
#>> @#>> @< =><
= > , > > >> 1.2.12 > > > @< @ > > 10
.
1.2.12 E> @< > 10
.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 18 ' 57
http://www.nice.org.uk/guidance/cg127http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/ph25http://www.nice.org.uk/guidance/cg43http://www.nice.org.uk/guidance/ph44http://www.nice.org.uk/guidance/ph44http://www.nice.org.uk/guidance/ph38http://www.nice.org.uk/guidance/cg15http://www.nice.org.uk/guidance/cg66http://www.nice.org.uk/guidance/cg87http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/cg87http://www.nice.org.uk/guidance/cg66http://www.nice.org.uk/guidance/cg15http://www.nice.org.uk/guidance/ph38http://www.nice.org.uk/guidance/ph44http://www.nice.org.uk/guidance/ph44http://www.nice.org.uk/guidance/cg43http://www.nice.org.uk/guidance/ph25http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/cg127
8/18/2019 Bipolar Disorder Assessment and Management
19/57
1.3 A&*/( &$&% #*" %*%& */ "% */ &$/%" $"&
1.3.1 A=> @ @ > =>=>, > >:
@=> @@
=@> @ >>
@ >=> =>
@ => > > => >>=>@ > > =@ @ > @== > $ICE <
> > @> > < >> > @ , @ > @ @ , =>> >> @ > > > >
, =@= > @, @ @ > @>
= >> > = >
< @' < >>> > > @<
@>< =>< > @< =
@>' @< => > , >
>
=> > > >>> >
> > @
> @@ =
8/18/2019 Bipolar Disorder Assessment and Management
20/57
@ > =, > @,
@< > @>< > @< > >
J@> @= , @> >
@< @- @=.
1.3.4 I @, @ => >
==>> 1.3.2 > @ >, @>> >
>, > @== @@. G @> > G&
@ @, > > @> 10
.
1.3.5 C => > >>> @> @ @ > , , > =, @>> =>
>< < @, @> > = > => ,
> > 1.4.
1.4 M"/"(*/( $**, * "/% #&)"* )" $)"&/(& */ "% *) #*"
%*%& */ &$/%" $"&
1.4.1 D=> @ >, >
@:
>N=>< > >
> > =@= ' > @> > >>
=> > >< => ( = > @> >
>) @@ => = > > >
=@= > >N
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 20 ' 57
http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guideline
8/18/2019 Bipolar Disorder Assessment and Management
21/57
=> > @= > > @> > >
> >> @=> > @> @,
@@@, , >> > , > >= @= > > > >.
G @> > G& @ @, > > @>
.
1.4.2 @@ @@
==>> 1.4.1.1L1.4.1.4 > $ICE < >
@ > J@> > >:
> @> > < =>>
>, > ==>> , > > @ >> .
1.5 M"/"(*/( "/*" )"/*" */ "% */ &$/%" $"&
@@ > @@ >
1.5.1 E> @@ @=>
>>=> > =. A = > = =@>
> >< = => @=> > >
= =>> @ @>>>
1.5.2 I @> @=> > > > >@> (
N> B >>< =@:
> @@> >@> >
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 21 ' 57
http://www.nice.org.uk/guidance/CG178/chapter/1-Recommendations#subsequent-acute-episodes-of-psychosis-or-schizophrenia-and-referral-in-crisis-2http://www.nice.org.uk/guidance/cg25http://www.nice.org.uk/guidance/cg136http://www.nice.org.uk/guidance/cg16http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.bnf.org/http://www.bnf.org/http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg16http://www.nice.org.uk/guidance/cg136http://www.nice.org.uk/guidance/cg25http://www.nice.org.uk/guidance/CG178/chapter/1-Recommendations#subsequent-acute-episodes-of-psychosis-or-schizophrenia-and-referral-in-crisis-2
8/18/2019 Bipolar Disorder Assessment and Management
22/57
> >@ > ==>> 1.5.3, @> @@.
1.5.3 I @> @=> > > > > >@
= , >> > > > =>, @>' @> > <
> (> @< =, @ @> => >
). F > > >@ >
> 1.10.
1.5.4 I N >@ @ @
>) > === , >
>@ = ==>> 1.5.3, > >> > > =>, @>' @> > < >
(> @< =, @ @> => >
).
1.5.5 I > >@ > N> > ,
> >), > > (
==>> > > 1.10).
1.5.6 I @> @=> > > > >@> (
N> B$F) > =>> = @@>
>@>.
1.5.7 I @> , @>> > @>' @> > @
@> =>.
1.5.8 I @> = >> , @ === B$F >, @>> > < @>. I >
=@=>, > >
@>, @>> > @>' @> > @ @>
=>. F > > >@ > > 1.10.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 22 ' 57
http://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.bnf.org/http://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.bnf.org/http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.bnf.org/http://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.bnf.org/http://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medication
8/18/2019 Bipolar Disorder Assessment and Management
23/57
1.5.9 I < @>> = ,
=> > @ =@=, 1.5.1L1.5.8
=> =>, > => .
1.5.10 D > =>.
EE > @>
>>>, $ICE' > >
=> =>> => =>
1.5.12 > 4 =@=, @>, >
@@@, >> => =>
-= => ( > 1.7). E@ @>< >N
-= => > , > =>
-= =>.
1.5.13 I @> >> => =>,
3-6 =>, > > .
1.6 M"/"(*/( #*" %&&*/ */ "% */ &$/%" $"&
&&>>>>
1.6.1 > > > (> < @,
>@>< @ < @ ==>>
1.5.3.1L1.5.3.5 > $ICE < > @>.
D @> @N > @>>
> @>. #> = > => @=> >
@ =@=.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 23 ' 57
http://www.nice.org.uk/guidance/ta59http://www.nice.org.uk/guidance/ta59http://www.nice.org.uk/guidance/cg185/chapter/recommendations#managing-bipolar-disorder-in-adults-in-the-longer-term-in-secondary-care-2http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/CG90/chapter/1-Guidance#psychological-interventionshttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#managing-bipolar-disorder-in-adults-in-the-longer-term-in-secondary-care-2http://www.nice.org.uk/guidance/ta59http://www.nice.org.uk/guidance/ta59
8/18/2019 Bipolar Disorder Assessment and Management
24/57
8/18/2019 Bipolar Disorder Assessment and Management
25/57
8/18/2019 Bipolar Disorder Assessment and Management
26/57
=> > >=> @= > >
@> > . * > >
=@=
@@> => > @
@>< >N > -= => > @>>, > > => = > =>
@>< >N > @@> =>, > => = = @>>
@>' @:
> > @ => @,
> > >>
@ @> =>
=@= > @
@>< >, > =>
@ =>, > > > > => @ $ICE' >=>
@ > > = @> > >>.
&&>>>>
1.7.2 =>> @@> 1.3.7.2 > $ICE
< > @ > J@> > > (> @ @-
=>< >
8/18/2019 Bipolar Disorder Assessment and Management
27/57
@@ =@= > @ =>
@.
1.7.4 I>< > @ @>> @
@ =@ > > = > =, >
=@ >>>
> > @> @> > =>> >><
N >:
>< @==
8/18/2019 Bipolar Disorder Assessment and Management
28/57
), > 18
> ,
> > > @ => @, @>.
D @> @N > =, > > > 1.10.
1.7.7 I @@> -= @=:
@> >
=@=
@ => => @> > > =>> =@=, = > =>< 2
=> @@ >> > @= (
==>> 1.9.3).
1.8 M/**/( )*$" )&") */ &$/%" $"&
1.8.1 H > , @
@== @@, @@ 1.2.10L1.2.14
@>> > > = > 10
.
1.8.2 &@, > @<
@== =>< @ >, >=< < , @< >> > $ICE > >
, @>> @ 2 10
.
1.8.4 > > =
= > @@<
= @10
.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 28 ' 57
http://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.nice.org.uk/Guidance/CG185/chapter/recommendations#return-to-primary-carehttp://www.nice.org.uk/guidance/cg185/chapter/1-recommendations#monitoring-physical-healthhttp://www.nice.org.uk/guidance/cg43http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/cg38http://www.nice.org.uk/guidance/cg38http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/cg43http://www.nice.org.uk/guidance/cg185/chapter/1-recommendations#monitoring-physical-healthhttp://www.nice.org.uk/Guidance/CG185/chapter/recommendations#return-to-primary-carehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medicationhttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#how-to-use-medication
8/18/2019 Bipolar Disorder Assessment and Management
29/57
1.8.5 * > >
=>> > => = @@
8/18/2019 Bipolar Disorder Assessment and Management
30/57
1.9.5 E> > @@ @> G& > @
> >.
E=@ > @>< =>, > > @><
1.9.6 @@ =@ @== @@ N> > . C>
@>< >< , > @->< >>,
@@< > N>> =@10
.
1.10 H & &%*$"*/
1.10.1 > > > @@ => @ :
@> > >=> =>> ,
> = > @@> >
=> = > @ > > ' @>
=> @ @@.
1.10.2 D >>-@@>
=> > @@@.
E@ @> > @
@ => > @>>10
.
1.10.3 > > @@ =>
=@ > > >>> > > > >>
> > > =@ > =>,
> , > > > >> > = =< = > > > .
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 30 ' 57
http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guideline
8/18/2019 Bipolar Disorder Assessment and Management
31/57
1.10.4 D > @>> @= @ >@+> >@ => =>
S"*/( "/* S"*/( "/*$)*$ &%*$"*/$)*$ &%*$"*/
1.10.5 B > >@ =>, = > @>':
B#I
@
8/18/2019 Bipolar Disorder Assessment and Management
32/57
D > > > B$F
&C.
> > > > > B$F &C, >
>= @> => >.
>>>, >> @@> =>, >
>10
.
M/**/( "/* M/**/( "/*$)*$ &%*$"*/$)*$ &%*$"*/
1.10.8 #> > > > >
> =@ > @< >>>
=> ==>
>10
.
1.10.9 * > = > @>>
N > >< @>' >> > = > @=
> - >=>10
.
1.10.10 I --> =>,
< @>
>> > => >.
1.10.11 'A ' (@..>.) @@> >@ => ==>> 1.10.7. < >>, >
=>>, @ >N > = >
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 32 ' 57
http://www.bnf.org/http://www.bnf.org/http://www.bnf.org/http://www.bnf.org/
8/18/2019 Bipolar Disorder Assessment and Management
33/57
>. E> @..>. @@> > >>>> >@ =>, @
@ ( =@ >> =>)11.
S*/( "/* S*/( "/*$)*$ %($)*$ %(
1.10.13 I @@> > >@ , @ >>> = >
' B#I > > > ECG @@ > @@@ >>< >=> (
8/18/2019 Bipolar Disorder Assessment and Management
34/57
> >< =@=>.
1.10.17 A @@ > =
> =>> O >, @
@> @>>
@>>.
1.10.18 > @@ --> >>-<
>->O== > @> @@ =>< .
M/**/( *)*M/**/( *)*
1.10.19 # @>' @
8/18/2019 Bipolar Disorder Assessment and Management
35/57
>> 6 =>, > = > > =@ ><
>>, = =@=
= >.
1.10.22 #> @
> .
1.10.28 A @@ , > > >
=@= == =<
8/18/2019 Bipolar Disorder Assessment and Management
36/57
1.10.29 > @> >
>> (@ ) >
J@> > =>.
M/**/( M/**/( " ""&"&
1.10.30 D > >' B#I > > > 6 => => @
>>, = > >
8/18/2019 Bipolar Disorder Assessment and Management
37/57
>< > > > &C >
B$F, > > > > > @@ >
.
1.10.37 A @@ :
> == @>> @>>.
M/**/( "*(*/&M/**/( "*(*/&
1.10.38 D > > .
S*/( "*(*/&S*/( "*(*/&
1.10.39 I @@> , >> > >> > @= > @
> @@ > @@ 14 , = =>< > @@ > @
CA#H = @ > => > =>=> @ ==>> > . * => @@
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 37 ' 57
http://www.bnf.org/http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.bnf.org/
8/18/2019 Bipolar Disorder Assessment and Management
38/57
= > =>>
@>> > @ >< >>>
@=>>
@> > =@> > > > @@ @@, @@ >< =>> < = > @> >
=>, > > =>=> @ >
> @@ > ' @>
.
1.11.5 > >> @ > @@
= @>
@ = @> > = > = =, >.
1.11.6 D > = > @ > @@
@> = > @>' >< > <
>>>.
#>=> > #>=> > > @@ @@ > => > @@ > < =, <
8/18/2019 Bipolar Disorder Assessment and Management
39/57
@ >> =>, @
> ==>> 1.3.5.
M"/*"M"/*"
1.11.9 * => @=> > > @@ > @- =>< > <
@ >@>< @, =
> > >< =>.
1.11.13 I >
==>> 1.3.5, > > > => @ > ==>> 1.4.1.
1.11.14 A = = >>, @> @< =< =>< > @ > @>,
@> = >< @>> > > =>< > @>, @> =
8/18/2019 Bipolar Disorder Assessment and Management
40/57
1.11.15 I > @>' @ = , >
@=>> > > @>>. F @=>>
> 1.623
B$F = =>, >
> >> >@ => > 12 . A
12 , @< > =>=> @> -= =>=>.
L/(-& "/"(&&/L/(-& "/"(&&/
1.11.16 A = >< => =>> @ > @@
=.
10A@ = & > J@> > J@> > +! < @, = @ (@= 2014)
+! => > >>, >
+! < @. * @ . I>= >> > =>.
G>< #< C> @> > =>> => >
>=>.
14A > +! < @, = @ (@= 2014),
O> > +! => > >>. * @ . I>= >>
> =>. G>< #< C>
8/18/2019 Bipolar Disorder Assessment and Management
41/57
15A = @ (@= 2014), J@> > +! =>
> >>. * @ . I>= >> > =>.
G>< #< C>
@> > =>> => > >=>.
17
A = @ (@= 2014) =-= > >> > @@ @> =>
=-= >
>>, > +! < @. * @ . I>= >> > =>. G>< #< C>
@> > =>> => > >=>.
19A @
=, > =@> < =@=, @ . @ >J= > => =@>
=@
@ 12 => = => @ > @ >
@@
8/18/2019 Bipolar Disorder Assessment and Management
42/57
22A = @ (@= 2014), J@>, @>, > >
> > @@>. * @ . I>= >> > =>.
G>< #< C> @> > =>> => > >=>.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 42 ' 57
http://www.gmc-uk.org/guidance/ethical_guidance/14316.asphttp://www.gmc-uk.org/guidance/ethical_guidance/14316.asphttp://www.gmc-uk.org/guidance/ethical_guidance/14327.asphttp://www.gmc-uk.org/guidance/ethical_guidance/14327.asphttp://www.gmc-uk.org/guidance/ethical_guidance/14327.asphttp://www.gmc-uk.org/guidance/ethical_guidance/14327.asphttp://www.gmc-uk.org/guidance/ethical_guidance/14316.asphttp://www.gmc-uk.org/guidance/ethical_guidance/14316.asp
8/18/2019 Bipolar Disorder Assessment and Management
43/57
22 ==>> ==>>
* G D G@ = > ,
> >, =@ $ICE > > @> > . * G
D G@' > > @>> >
@@ =@>
* > >< >
@ @>> > > @@@ > > > @@ >
< @ (CB*), >@>< @ (I&*) > -= = > @ < > >>< = > @@ >> =@ > >> > >
@ > >@, =@> > = @ >N > @@ >= >> (CB* =@ I&*). I>>> ,
9-=> >< = > => > 9-=> .
2.2 M"*/&/"/$& &"&/
I> =>>> => @>
> >@?
=@> =@>
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 43 ' 57
http://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guidelinehttp://www.nice.org.uk/guidance/cg185/chapter/recommendations#terms-used-in-this-guideline
8/18/2019 Bipolar Disorder Assessment and Management
44/57
"= > >@ => >> -=
> @@ , > N, >. >=> =@> @@ @> = .
* @== @ >@ =>@ ( @>)
> =>> > >@. *
8/18/2019 Bipolar Disorder Assessment and Management
45/57
=>, >>, > =@=, => => @=> =@=,
=, .
2.4 A &$*"*&% $"#"*& $"& &*$& ' && *) #*" %*%&
< > > @ 2 (= D>= > +A). * > > > >= >, > > > @. F @ > @ @>
=@=, >>, > < .
2.5 C(/**& #&)"*" )&" ' )& /(-& "/"(&&/ ' #*"
%*%&
< > > -- > < @ (CB*)
=@ >>- -= =>=> @ =@>
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 45 ' 57
8/18/2019 Bipolar Disorder Assessment and Management
46/57
* G D G@ > >< @>>
-=
>N >>- >>> >-< > -- CB* > = - > > - @>> , @ @>< @>; (2) 2-= >>->
C* =@> >>-< -- CB* > @ > > = >
. * @= = < > >, >
>.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 46 ' 57
8/18/2019 Bipolar Disorder Assessment and Management
47/57
33 >=> >=>
3.1 S$& "/% ) )* (*%&*/& " %&&&%
$ICE > @ N>
.
H H < C #>< H > >.
* = > @ $ICE < > * =>=> 138
@> > < 136
#> > (2009) $ICE < 76
&=> =>< -= > > >@ (2009) $ICE @ >
59
C/%**/-&$*$C/%**/-&$*$
C> > (2014) $ICE < 182
"@ =N> (2014) $ICE < 181
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 47 ' 57
http://www.nice.org.uk/guidance/CG185/Documentshttp://www.nice.org.uk/guidance/cg185/chapter/the-guideline-development-group-national-collaborating-centre-and-nice-project-teamhttp://www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-guidelines/NICE-clinical-guidelineshttp://www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-guidelines/NICE-clinical-guidelineshttp://www.nice.org.uk/http://www.nice.org.uk/guidance/cg138http://www.nice.org.uk/guidance/cg136http://www.nice.org.uk/guidance/cg76http://www.nice.org.uk/guidance/ph22http://www.nice.org.uk/guidance/ph19http://www.nice.org.uk/guidance/ta59http://www.nice.org.uk/guidance/cg182http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/cg181http://www.nice.org.uk/guidance/cg182http://www.nice.org.uk/guidance/ta59http://www.nice.org.uk/guidance/ph19http://www.nice.org.uk/guidance/ph22http://www.nice.org.uk/guidance/cg76http://www.nice.org.uk/guidance/cg136http://www.nice.org.uk/guidance/cg138http://www.nice.org.uk/http://www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-guidelines/NICE-clinical-guidelineshttp://www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-guidelines/NICE-clinical-guidelineshttp://www.nice.org.uk/guidance/cg185/chapter/the-guideline-development-group-national-collaborating-centre-and-nice-project-teamhttp://www.nice.org.uk/guidance/CG185/Documents
8/18/2019 Bipolar Disorder Assessment and Management
48/57
& > J@> > > (2013) $ICE < 169
< > (2013) $ICE < 159
& > J@> > > > @@ @ > @ 292
=> (2011) $ICE < 133
& > > = (2011) $ICE < 120
A @> ( @) > > @< < @>> N @ (2008) $ICE < 72
*@ 2 (2008) $ICE < 66
D =: @ N> (2007) $ICE < 52
D =: @< >>> (2007) $ICE < 51
A>>< > @>< =>< @>> (2006) $ICE >
94
-=@ =@ (2005) $ICE <
31
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 48 ' 57
http://www.nice.org.uk/guidance/cg178http://www.nice.org.uk/guidance/cg169http://www.nice.org.uk/guidance/cg159http://www.nice.org.uk/guidance/cg155http://www.nice.org.uk/guidance/ta292http://www.nice.org.uk/guidance/ta292http://www.nice.org.uk/guidance/cg133http://www.nice.org.uk/guidance/cg120http://www.nice.org.uk/guidance/cg115http://www.nice.org.uk/guidance/cg113http://www.nice.org.uk/guidance/cg91http://www.nice.org.uk/guidance/cg90http://www.nice.org.uk/guidance/cg78http://www.nice.org.uk/guidance/cg77http://www.nice.org.uk/guidance/cg72http://www.nice.org.uk/guidance/cg66http://www.nice.org.uk/guidance/cg52http://www.nice.org.uk/guidance/cg51http://www.nice.org.uk/guidance/cg45http://www.nice.org.uk/guidance/cg43http://www.nice.org.uk/guidance/ta94http://www.nice.org.uk/guidance/cg31http://www.nice.org.uk/guidance/cg31http://www.nice.org.uk/guidance/ta94http://www.nice.org.uk/guidance/cg43http://www.nice.org.uk/guidance/cg45http://www.nice.org.uk/guidance/cg51http://www.nice.org.uk/guidance/cg52http://www.nice.org.uk/guidance/cg66http://www.nice.org.uk/guidance/cg72http://www.nice.org.uk/guidance/cg77http://www.nice.org.uk/guidance/cg78http://www.nice.org.uk/guidance/cg90http://www.nice.org.uk/guidance/cg91http://www.nice.org.uk/guidance/cg113http://www.nice.org.uk/guidance/cg115http://www.nice.org.uk/guidance/cg120http://www.nice.org.uk/guidance/cg133http://www.nice.org.uk/guidance/ta292http://www.nice.org.uk/guidance/ta292http://www.nice.org.uk/guidance/cg155http://www.nice.org.uk/guidance/cg159http://www.nice.org.uk/guidance/cg169http://www.nice.org.uk/guidance/cg178
8/18/2019 Bipolar Disorder Assessment and Management
49/57
&-= (2005) $ICE < 26
(2005) $ICE < 25
+>
$ICE ( @>< =>< >. $ICE < . & @ A@< 2015.
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 49 ' 57
http://www.nice.org.uk/guidance/cg26http://www.nice.org.uk/guidance/cg25http://www.nice.org.uk/guidance/cg16http://www.nice.org.uk/guidance/cg15http://www.nice.org.uk/http://www.nice.org.uk/Guidance/InDevelopment/GID-CGWAVE0598http://www.nice.org.uk/Guidance/InDevelopment/GID-CGWAVE0619http://www.nice.org.uk/Guidance/InDevelopment/GID-CGWAVE0619http://www.nice.org.uk/Guidance/InDevelopment/GID-CGWAVE0598http://www.nice.org.uk/http://www.nice.org.uk/guidance/cg15http://www.nice.org.uk/guidance/cg16http://www.nice.org.uk/guidance/cg25http://www.nice.org.uk/guidance/cg26
8/18/2019 Bipolar Disorder Assessment and Management
50/57
44 * G D* G D G@, $>< C C>
> $ICE @ => $ICE @ =
4.1G*%&*/& D&&&/ G
# #
& & > C==> H $>=; H> C>
&, $>= H B>
G&, & ", &>>
& C@>A> C@>
> C< , D@=> &, +> ; H> C>
&, H> *
A>>A>> = =
C> C A &, HN; H> > ", +>
C> >C> >
@>> >
> >> >
& C< & D, @= C> #>< H C< & $>, $
C< &C< &>>
C &=, > *
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 50 ' 57
8/18/2019 Bipolar Disorder Assessment and Management
51/57
# # >>>>
& C< & E>
D>> >>D>> >>
> *@, * C>, *, E > *
@>> >
FF
A@@ #>< H < #>< H
8/18/2019 Bipolar Disorder Assessment and Management
52/57
CC >> >>
> = (= F 2014); A D (C< E>)
4.3 NICE +&$ &"
8/18/2019 Bipolar Disorder Assessment and Management
53/57
C> @C> @
FF 2016: 2016: * #> > H= >
@>>. H >>>
. F> >
#HA' .
A@< 2015:A@< 2015: ==>> 1.5.5, 1.5.8 > 1.7.6 > 1.10 .
==>> > > 1.10 >
==>> > < => @>< . *
> > #> > H> > 2015:> 2015: * #> > H> >> > => @> =>>>
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 53 ' 57
https://www.gov.uk/government/publications/toolkit-on-the-risks-of-valproate-medicines-in-female-patientshttps://www.gov.uk/government/publications/toolkit-on-the-risks-of-valproate-medicines-in-female-patientshttps://www.gov.uk/government/publications/toolkit-on-the-risks-of-valproate-medicines-in-female-patientshttps://www.gov.uk/government/publications/toolkit-on-the-risks-of-valproate-medicines-in-female-patients
8/18/2019 Bipolar Disorder Assessment and Management
54/57
A A
$ICE < ==>> => > @@ >>.
$ICE > @ N>
.
* < C #>< H >),
@> > , > >< , > >
==>>. * ==>> N> @ $ICE < > *
=>, > > >=> > ==>> > @> - I. D> > $ICE > >
@ @@ > = => > =>, >=>, > $> I E. $ICE > @ = > >> @@> @> =
>.
U%"& */'"*/
* @ > @
8/18/2019 Bipolar Disorder Assessment and Management
55/57
F >, $ICE @ > @> >
>N >>>, > @>. * > = ).
I>I>>> = (>> = ( = >) = >)
> > > >> > > ) L '>' ==>>
'' (> = >N> , = @>, > >>> =, > .
= >N> > >>>
>N = @>.
I>I>>> > >N> > >>> =
= @>, > , @> = =>, > > >>> => @ > @@ @= > > , >>
> < H> = > >@ > $ICE &.
@ >=> @
8/18/2019 Bipolar Disorder Assessment and Management
56/57
I&&/"*/
I=@> @ >
> . H, > > ><
@>
>< @>, > > @> >/ > , > >=
== @ > .
I=@> > @>/ @.
C==> > @ => @>, > , >
>>, > > . $> >
> @ > >> =@
.
C*()
K $>< I> H C E , > = @ ><
> >--@N @@. $ @> ==< >>,
==< @@, $ICE.
IB$: 978-1-4731-0721-2
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
/ NICE 2014. A$$ #!"+* e*e-ed. La*+ %'d#ed Feba 2016 Pa!e 56 ' 57
http://www.nice.org.uk/Guidance/CG185/Resourceshttp://www.nice.org.uk/Guidance/CG185/Resources
8/18/2019 Bipolar Disorder Assessment and Management
57/57
A$$&%*"*/
B#'$a d#*'de: +"e a**e**%e&+ a&d %a&a!e%e&+ ' b#'$a d#*'de #& ad$+*, c"#$de& a&d '&!
e'$e #& #%a a&d *ec'&da cae (CG185)
http://www.nice.org.uk/http://www.nice.org.uk/